Efficacy and Safety of Hydrocodone Bitartrate in Patients With Osteoarthritis or Low Back Pain

Study Title
Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time
Teva Identifier
C33237/3079
ClinicalTrials.gov Identifier
NCT01240863
Study Status
Completed
Trial Condition(s)
Chronic Pain
Interventions
Drug: Hydrocodone ER | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial



Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 80 Years
Trial Duration
11/01/2010 - 08/01/2011
Phase
Phase 3

Study Type

Interventional